Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis
- PMID: 19304859
- DOI: 10.1177/0269881109103227
Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis
Abstract
Deficits in attentional functions belong to the core cognitive symptoms in schizophrenic patients. Alertness is a nonselective attention component that refers to a state of general readiness that improves stimulus processing and response initiation. The main goal of the present study was to investigate cerebral correlates of alertness in the human 5HT(2A) agonist and N-methyl-D-aspartic acid (NMDA) antagonist model of psychosis. Fourteen healthy volunteers participated in a randomized double-blind, cross-over event-related functional magnetic resonance imaging (fMRI) study with dimethyltryptamine (DMT) and S-ketamine. A target detection task with cued and uncued trials in both the visual and the auditory modality was used. Administration of DMT led to decreased blood oxygenation level-dependent response during performance of an alertness task, particularly in extrastriate regions during visual alerting and in temporal regions during auditory alerting. In general, the effects for the visual modality were more pronounced. In contrast, administration of S-ketamine led to increased cortical activation in the left insula and precentral gyrus in the auditory modality. The results of the present study might deliver more insight into potential differences and overlapping pathomechanisms in schizophrenia. These conclusions must remain preliminary and should be explored by further fMRI studies with schizophrenic patients performing modality-specific alertness tasks.
Similar articles
-
Pharmacological modulation of the neural basis underlying inhibition of return (IOR) in the human 5-HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology (Berl). 2008 Nov;200(4):573-83. doi: 10.1007/s00213-008-1237-1. Epub 2008 Jul 24. Psychopharmacology (Berl). 2008. PMID: 18649072 Clinical Trial.
-
Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology (Berl). 2008 Jul;199(1):77-88. doi: 10.1007/s00213-008-1129-4. Epub 2008 May 18. Psychopharmacology (Berl). 2008. PMID: 18488201 Free PMC article. Clinical Trial.
-
Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.Neuropsychopharmacology. 2006 Feb;31(2):431-41. doi: 10.1038/sj.npp.1300882. Neuropsychopharmacology. 2006. PMID: 16123739 Clinical Trial.
-
[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].Encephale. 2001 Jan-Feb;27(1):53-9. Encephale. 2001. PMID: 11294039 Review. French.
-
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia.Schizophr Bull. 2012 Sep;38(5):958-66. doi: 10.1093/schbul/sbs069. Schizophr Bull. 2012. PMID: 22987851 Free PMC article. Review.
Cited by
-
Clinical applications of hallucinogens: A review.Exp Clin Psychopharmacol. 2016 Aug;24(4):229-68. doi: 10.1037/pha0000084. Exp Clin Psychopharmacol. 2016. PMID: 27454674 Free PMC article. Review.
-
Psychedelics and fNIRS neuroimaging: exploring new opportunities.Neurophotonics. 2023 Jan;10(1):013506. doi: 10.1117/1.NPh.10.1.013506. Epub 2022 Dec 2. Neurophotonics. 2023. PMID: 36474478 Free PMC article.
-
Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency.Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):403-14. doi: 10.1007/s00406-011-0281-8. Epub 2011 Dec 22. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 22189657 Clinical Trial.
-
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.Front Neurosci. 2018 Aug 6;12:536. doi: 10.3389/fnins.2018.00536. eCollection 2018. Front Neurosci. 2018. PMID: 30127713 Free PMC article. Review.
-
The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.Cureus. 2022 Sep 14;14(9):e29167. doi: 10.7759/cureus.29167. eCollection 2022 Sep. Cureus. 2022. PMID: 36259015 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources